Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Fazio

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|September 11, 2008
The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBSGiuseppina Novo, Daniela Guttilla, Giovanni Fazio, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 23, 2007
The total absence of atrial automaticity in a child with sinus node dysfunctionFabrizio Drago, Giovanni Fazio, Alfredo Di Pino, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Delayed MRI hyperenhancement in noncompaction: sign of fibrosis correlated with clinical severityGiovanni Fazio, Claudia Visconti, Luciana D'Angelo, et al.
Clinical Drug Investigation|September 8, 2018
Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal ImpairmentGiovanni Fazio, Ilaria Dentamaro, Rosanna Gambacurta, et al.
Current Pharmaceutical Design|July 17, 2010
Diagnosis and prognosis of fetal cardiomyopathies: a reviewMaurizio Mongiovì, Vlasta Fesslova, Giovanni Fazio, et al.
Current Pharmaceutical Design|April 9, 2008
Transcatheter ablation of supraventricular tachycardias in pediatric patientsAntonella De Santis, Giovanni Fazio, Massimo Stefano Silvetti, et al.
Pharmaceuticals (Basel, Switzerland)|October 11, 2016
Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124Salvatore Novo, Giovanni Fazio, Elena Raccuglia, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 20, 2013
Role of bisoprolol in patients with long QT syndromeGiovanni Fazio, Federica Vernuccio, Giuseppe Lo Re, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Biomarkers in heart failureGiuseppina Novo, Gisella Rita Amoroso, Giovanni Fazio, et al.
Current Pharmaceutical Design|November 11, 2008
The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndromeGiovanni Fazio, Gisella Rita Amoroso, Giuseppe Barbaro, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|September 11, 2008
The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBSGiuseppina Novo, Daniela Guttilla, Giovanni Fazio, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 23, 2007
The total absence of atrial automaticity in a child with sinus node dysfunctionFabrizio Drago, Giovanni Fazio, Alfredo Di Pino, et al.
AJR. American Journal of Roentgenology|March 22, 2008
Delayed MRI hyperenhancement in noncompaction: sign of fibrosis correlated with clinical severityGiovanni Fazio, Claudia Visconti, Luciana D'Angelo, et al.
Clinical Drug Investigation|September 8, 2018
Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal ImpairmentGiovanni Fazio, Ilaria Dentamaro, Rosanna Gambacurta, et al.
Current Pharmaceutical Design|July 17, 2010
Diagnosis and prognosis of fetal cardiomyopathies: a reviewMaurizio Mongiovì, Vlasta Fesslova, Giovanni Fazio, et al.
Current Pharmaceutical Design|April 9, 2008
Transcatheter ablation of supraventricular tachycardias in pediatric patientsAntonella De Santis, Giovanni Fazio, Massimo Stefano Silvetti, et al.
Pharmaceuticals (Basel, Switzerland)|October 11, 2016
Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124Salvatore Novo, Giovanni Fazio, Elena Raccuglia, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 20, 2013
Role of bisoprolol in patients with long QT syndromeGiovanni Fazio, Federica Vernuccio, Giuseppe Lo Re, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Biomarkers in heart failureGiuseppina Novo, Gisella Rita Amoroso, Giovanni Fazio, et al.
Current Pharmaceutical Design|November 11, 2008
The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndromeGiovanni Fazio, Gisella Rita Amoroso, Giuseppe Barbaro, et al.
Pageof 9